Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Buy-out potential???

<< Previous

Bullboard Posts

Next >>

Comment by Cblifeformson Oct 04, 2023 11:40am

194 Views

Post# 35669141

RE:Buy-out potential???

Drug easy to manufacture and reliable in the effects... investing on this in 2023 is a no brainer at this stock price (I think it loosed something like 98% with inflaction included since beginning 25 years ago). So put some money there and forget: this is my position. Shorts are just crazy people shorting this.

<< Previous

Bullboard Posts

Next >>

Get a better understanding of the psychology of options trading